Dual Effect of Nitrate Therapy for Cyclosporine-Induced Hypertension on Vascular and Platelet Morphofunctional Markers; An Animal Model

Transplantation Proceedings

Volumn 39, Issue 8, 2007, Pages 2501-2506

  Reis, F ^a   Teixeira de Lemos, E ^a   Almeida, L ^a   Parada, B ^a,b   Garrido, A P ^a   Rocha Pereira, P ^c,e   Santos Silva, A ^d,e   Santos Dias, J ^f   Dinis, A ^f   Figueiredo, A ^b   Costa Almeida, C ^a   Mota, A ^b   Teixeira, F ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

^f UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ISOSORBIDE 5 NITRATE; MONOPRONT; PROSTACYCLIN; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG ANTAGONISM; HEMODYNAMICS; HYPERTENSION; LIPID BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE STRUCTURE; VASCULAR LESION;

ADENOSINE DIPHOSPHATE; ANIMALS; AORTA; BLOOD PLATELETS; BLOOD PRESSURE; CYCLOSPORINE; EPOPROSTENOL; HYPERTENSION; LIPIDS; MALE; MODELS, ANIMAL; NITRATES; PLATELET AGGREGATION; RATS; RATS, WISTAR; THROMBOXANE A2;

EID: 35348827321     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.07.029     Document Type: Article

References (22)

1. Cortesini R. Cyclosporine-lessons from the first 20 years. Transplant Proc 36 2 suppl (2004) 158S
2. Vitko S., and Viklicky O. Cyclosporine renal dysfunction. Transplant Proc 36 2 suppl (2004) 243S
3. Taler S.J., Textor S.C., Canzanello V.J., et al. Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf 20 (1999) 437
4. Textor S.C., Taler S.J., Canzanello V.J., et al. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl 6 (2000) 521
5. Kokado Y., Takahara S., Kamoeka H., et al. Hypertension in renal transplant recipients and its effect on long-term renal allograft survival. Transplant Proc 28 (1996) 1600
6. Cosio F.G., Falhenhain M.E., Pesavento T.E., et al. Relationship between arterial hypertension and renal allograft survival in African-American patients. Am J Kidney Dis 29 (1997) 419
7. Olyaei A.J., de Mattos A.M., and Bennett W.M. A practical guide to the management of hypertension in renal transplant recipients. Drugs 58 (1999) 1011
8. Cartier R., Dagenais F., Hollmann C., et al. Chronic exposure to cyclosporine affects endothelial and smooth muscle reactivity in the rat aorta. Ann Thorac Surg 58 (1994) 789
9. Vaziri N.D., Ni Z., Zhang Y.P., et al. Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension. Kidney Int 54 (1998) 482
10. Santiago M., Reis F., Almeida L., et al. Impairment of vascular and platelet nitric oxide and 3′, 5′ cyclic guanosine monophosphate content in cyclosporine A-induced hypertensive rats. Fund Clin Pharmacol 17 (2003) 43
11. Oriji G.K., and Keiser H.R. Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 32 (1998) 849
12. Anderson T.J. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev 8 (2003) 71
13. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 88 (2001) 756
14. Reis F., Santiago M., Almeida L., et al. Isosorbide-5-mononitrate and L-arginine effect on the cyclosporin-induced arterial hypertension and vascular nitric oxide impairment. In: Tooke J., Shore A., and Whatmore J. (Eds). The Microcirculation and Vascular Biology (2002), Italy Monduzzi Editore S.p.A, Bologna 257
15. Lassila M., Santisteban J., Finckenberg P., et al. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. J Physiol Pharmacol 52 (2001) 21
16. Gunasekara N.S., and Noble S. Isosorbide 5-mononitrate. A review of a sustained-release formulation (Indur) in stable angina pectoris. Drugs 57 (1999) 261
17. Parker J.O. Angina pectoris: a review of current and emerging therapies. Am J Manag Care 10 11 suppl (2004) S332
18. Reis F., Tavares P., Fontes-Ribeiro C.A., et al. The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats. Thromb Res 96 (1999) 365
19. Martin A., Wong K.S., Li M., et al. Cyclosporin hypertension in the Wistar rat: role of uninephrectomy. Clin Exp Pharmacol Physiol 21 (1994) 287
20. Reis F., Tavares P., Rito L.C., et al. Platelet activation is increased in cyclosporin A-induced hypertensive rats. J Cardiovasc Pharmacol 36 (2000) 56
21. Channon K.M., and Guzik T.J. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 53 (2002) 515
22. Brown A.S., Moro M.A., Masse J.M., et al. Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite. Cardiovasc Res 40 (1998) 380